Neuroendocrine carcinoma are high-grade malignant neoplasms with cells that express little or no chromogranin A, somatostatin receptors, or hormones; however, high expression of INSM1 and synaptophysin has been observed in neuroendocrine carcinoma. This evidence concerns the gene CHGA and neuroendocrine carcinoma.